Mean platelet volume is increased in patients with hypertensive crises

References

• Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281–1357
   PubMed Web of Science ®Google Scholar
• Van den Born BJ, Beutler JJ, Gaillard CA. Dutch guideline for the management of hypertensive crisis – 2010 revision. Neth J Med 2011;69:248–255
   PubMed Web of Science ®Google Scholar
• Gonzalez R, Morales E, Segura J, Ruilope LM, Praga M. Long-term renal survival in malignant hypertension. Nephrol Dial Transplant 2010;25:3266–3272
   PubMed Web of Science ®Google Scholar
• Nadar S, Blann AD, Lip GY. Platelet morphology and plasma indices of platelet activation in essential hypertension: Effects of amlodipine-based antihypertensive therapy. Ann Med 2004;36:552–557
   PubMed Web of Science ®Google Scholar
• Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: Is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003;9:177–190
   PubMed Web of Science ®Google Scholar
• Bath P, Algert C, Chapman N, Neal B. PROGRESS Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004;35:622–626
   PubMed Web of Science ®Google Scholar
• Boos CJ, Beevers GD, Lip GY. Assessment of platelet activation indices using the ADVIATM 120 amongst ‘high-risk' patients with hypertension. Ann Med 2007;39:72–78
   PubMed Web of Science ®Google Scholar
• Park Y, Schoene N, Haris W. Mean platelet volume as an indicator of platelet activation: Methodological issues. Platelets 2002;13:301–306
   PubMed Web of Science ®Google Scholar
• Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: A link between thrombosis and inflammation? Curr Pharm Des 2011;17:47–58
   PubMed Web of Science ®Google Scholar
• Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996;7:157–161
   PubMed Web of Science ®Google Scholar
• Siebers R, Maling T. Mean platelet volume in human essential hypertension. J Hum Hypertens 1995;9:207
   PubMed Web of Science ®Google Scholar
• Coban E, Yazicioglu G, Berkant Avci A, Akcit F. The mean platelet volume in patients with essential and white-coat hypertension. Platelets 2005;16:435–438
   PubMed Web of Science ®Google Scholar
• Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol 2004;44:415–422
   PubMed Web of Science ®Google Scholar
• Yarlioglues M, Kaya MG, Ardic I, Dogdu O, Kasapkara HA, Gunturk E, Akpek M, Kalay N, Dogan A, Ozdogru I, et al. Relationship between mean platelet volume levels and subclinical target organ damage in newly diagnosed hypertensive patients. Blood Press 2011;20:92–97
   PubMed Web of Science ®Google Scholar
• Bulur S, Onder HI, Aslantas Y, Ekinozu I, Kilic AC, Yalcin S, Bulur S, Ozhan H. Relation between indices of end-organ damage and mean platelet volume in hypertensive patients. Blood Coagul Fibrinolysis 2012;23:367–369
   PubMed Web of Science ®Google Scholar
• Gasparyan AY, Stavropoulos-Kalinoglou A, Toms TE, Douglas KM, Kitas GD. Association of mean platelet volume with hypertension in rheumatoid arthritis. Inflamm Allergy Drug Targets 2010;9:45–50
   PubMedGoogle Scholar
• Ault MJ, Ellrodt AG. Pathophysiological events leading to the end-organ effects of acute hypertension. Am J Emerg Med 1985;3:10–15
   PubMed Web of Science ®Google Scholar
• Wallach R, Karp RB, Reves JG, Oparil S, Smith LR, James TN. Pathogenesis of paroxysmal hypertension developing during and after coronary bypass surgery: A study of hemodynamic and humoral factors. Am J Cardiol 1980;46:559–565
   PubMed Web of Science ®Google Scholar
• Punda A, Polic S, Rumboldt Z, Bagatin J, Marković V, Lukin A. Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: Randomized crossover trial. Croat Med J 2005;46:219–224
   PubMed Web of Science ®Google Scholar
• Martin JF, Trowbridge EA, Salmon GL, Plumb J. The biological significance of platelet volume: Its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983;32:443–460
   PubMed Web of Science ®Google Scholar
• Jakubowski JA, Thompson CB, Vaillancourt R, Valeri CR, Deykin D. Arachidonic acid metabolism by platelets of differing size. Br J Haematol 1983;53:503–511
   PubMed Web of Science ®Google Scholar